UNLOCKING THE POWER OF BIOSENSORS.

Aqsens Health's phage-biosensors represent cutting-edge technology for rapid, accurate, and affordable disease detection and monitoring. By leveraging the power of engineered phages and non-invasive biological sampling, the company seeks to renew the global healthcare diagnostics market and unlock the potential of personalized treatment response measurement.

Exploring the advantages of biosensors in disease detection

Icon of a specimen jar and test tube with lids, used in laboratory or medical testing contexts, outlined in black on a white background.

Non-invasive.

Unlike most screening and diagnostic methods, Aqsens Health’s biosensor method is non-invasive. It utilizes easily obtainable biological samples, such as saliva and urine, for analysis. Other sample types like sputum and serum can also be used when necessary.

Three overlapping circles with shaded intersections

Multi-omics Ready.

Analysis of biological samples, their metabolic changes and new biomarkers offers complementary data for multi-omics diagnostics, significantly improving accuracy over current gold standard tests and enabling feasible large-scale screening for severe diseases.

High Specificity.

Accurate and reliable results are crucial for successful screening and diagnostics.

Our biosensors excel in sensitivity and specificity compared to industry standards.

Two hands surrounding a dollar sign, representing financial protection or savings.

Cost-Efficient.

To make large-scale screening possible, the test and process must be scalable and affordable. Biosensor-based screening tests offer a unique cost structure that enables population level screening at an unprecedented scale and cost.